InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Riley Jeffrey Scott. Director active across 1 company, notably Gain Therapeutics, Inc.. Aggregated, 1 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €107k. Activity tracked since 28 March 2024. The latest transaction was filed on 28 March 2024 (Acquisition). Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration